Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Irritable Bowel Syndrome I: Introduction01:17

Irritable Bowel Syndrome I: Introduction

864
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
864
Bacterial Flora of the Large Intestine01:29

Bacterial Flora of the Large Intestine

1.4K
The gut microbiome is formed by a vast and diverse community of bacteria that colonizes our large intestine. These bacteria start residing in the gut from birth and continue diversifying throughout life, influenced by factors such as diet, lifestyle, and stress. The gut bacterial community also includes bacteria from food and those that enter the colon through the anus.
The normal gut flora of the colon plays a critical role in generating essential vitamins such as vitamins K, B5, and B7.
1.4K
What is Monogastric Digestion?01:50

What is Monogastric Digestion?

74.8K
The human body contains a monogastric digestive system. In a monogastric digestive system, the stomach only contains one chamber in which it digests food. Several other animal species also have monogastric digestive systems, including pigs, horses, dogs, and birds. This chapter, however, focuses on the human digestive system.
74.8K
Anatomy of the Intestines01:23

Anatomy of the Intestines

86.4K
Although digestion of proteins, carbohydrates, and lipids may begin in the stomach, it is completed in the intestine. The absorption of nutrients, water, and electrolytes from food and drink also occurs in the intestine. The intestines can be divided into two structurally distinct organs—the small and large intestines.
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the...
86.4K
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

701
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
701
Gastrointestinal Motility Disorders01:20

Gastrointestinal Motility Disorders

999
Gastrointestinal or GI motility disorders are characterized by irregular gastrointestinal tract movements, disrupting food transit from the mouth to the anus. They are caused by damage or dysfunction in gut muscles or nerves. These disorders can cause symptoms such as severe constipation, diarrhea, abdominal pain, and swallowing difficulties. Disorders can affect any segment of the GI tract and range widely in severity, from common conditions like GERD to life-threatening conditions like...
999

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Chronic stress unleashes an intratumor phage-fibroblast-B cell circuit to promote tumor growth.

Cancer cell·2026
Same author

Activated T cell extracellular vesicle DNA transfer enhances antigen presentation and anti-tumor immunity.

Cancer cell·2026
Same author

Increased <i>S. epidermidis</i> in the airway-gut microbiome of infants with bronchopulmonary dysplasia.

bioRxiv : the preprint server for biology·2026
Same author

Microbiota regulation of gut-brain neuroimmune crosstalk in early life.

International immunology·2025
Same author

Gut microbiota promotes immune tolerance at the maternal-fetal interface.

Cell·2025
Same author

A mother's touch: microbial guardians of early immune imprinting.

Trends in immunology·2025

Related Experiment Video

Updated: Dec 30, 2025

Injections of Lipopolysaccharide into Mice to Mimic Entrance of Microbial-derived Products After Intestinal Barrier Breach
08:24

Injections of Lipopolysaccharide into Mice to Mimic Entrance of Microbial-derived Products After Intestinal Barrier Breach

Published on: May 2, 2018

20.3K

LOS in The Dysbiotic Gut.

Katherine Z Sanidad1, Melody Y Zeng2

  • 1Gale and Ira Drukier Institute for Children's Health, Weill Cornell Medicine, New York City, NY, USA; Department of Pediatrics, Weill Cornell Medicine, New York City, NY, USA.

Cell Host & Microbe
|January 18, 2020
PubMed
Summary

Singer et al. discovered mechanisms to prevent gut bacteria overgrowth in newborns, stopping systemic spread and sepsis. This research offers insights into maintaining a healthy neonatal gut microbiome.

More Related Videos

Using Multi-fluorinated Bile Acids and In Vivo Magnetic Resonance Imaging to Measure Bile Acid Transport
08:42

Using Multi-fluorinated Bile Acids and In Vivo Magnetic Resonance Imaging to Measure Bile Acid Transport

Published on: November 27, 2016

11.5K
Assessment of Gut Barrier Integrity in Mice Using Fluorescein-Isothiocyanate-Labeled Dextran
05:14

Assessment of Gut Barrier Integrity in Mice Using Fluorescein-Isothiocyanate-Labeled Dextran

Published on: November 18, 2022

11.4K

Related Experiment Videos

Last Updated: Dec 30, 2025

Injections of Lipopolysaccharide into Mice to Mimic Entrance of Microbial-derived Products After Intestinal Barrier Breach
08:24

Injections of Lipopolysaccharide into Mice to Mimic Entrance of Microbial-derived Products After Intestinal Barrier Breach

Published on: May 2, 2018

20.3K
Using Multi-fluorinated Bile Acids and In Vivo Magnetic Resonance Imaging to Measure Bile Acid Transport
08:42

Using Multi-fluorinated Bile Acids and In Vivo Magnetic Resonance Imaging to Measure Bile Acid Transport

Published on: November 27, 2016

11.5K
Assessment of Gut Barrier Integrity in Mice Using Fluorescein-Isothiocyanate-Labeled Dextran
05:14

Assessment of Gut Barrier Integrity in Mice Using Fluorescein-Isothiocyanate-Labeled Dextran

Published on: November 18, 2022

11.4K

Area of Science:

  • Microbiology
  • Neonatal Health
  • Immunology

Background:

  • The neonatal gut microbiome is dynamic and influenced by nutrition and environment.
  • Gut-derived pathobionts can cause systemic infections like sepsis in newborns.
  • Understanding mechanisms to control pathobiont expansion is crucial for neonatal health.

Purpose of the Study:

  • To elucidate mechanisms inhibiting pathobiont expansion in the neonatal gut.
  • To prevent systemic dissemination of gut-derived pathobionts.
  • To reduce the incidence of neonatal sepsis.

Main Methods:

  • Utilized a neonatal mouse model with a dysbiotic gut microbiome.
  • Investigated molecular and cellular mechanisms controlling pathobiont populations.
  • Assessed the impact of these mechanisms on systemic pathogen dissemination.

Main Results:

  • Identified specific mechanisms that restrict the growth of gut pathobionts.
  • Demonstrated prevention of systemic spread of pathobionts from the gut.
  • Showed a reduction in sepsis incidence in treated neonatal mice.

Conclusions:

  • The study identifies key host-microbe interactions that maintain neonatal gut homeostasis.
  • These findings provide potential therapeutic targets for preventing neonatal sepsis.
  • Effective control of gut pathobionts is vital for neonatal survival and health.